Surgical Science Sweden AB Stock
Stocks
SUS
SE0014428512
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
13:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 58.30 SEK | -2.26% |
|
+1.48% | +79.38% |
| 10-21 | Danske Bank raises its price target for Surgical Science to SEK 70 (60), reiterates buy - BN | FW |
| 10-16 | Pareto raises target price for Surgical Science, sees margin target within reach | FW |
| Market Cap | 3.04B 309M 277M 255M 231M 432M 29.4B 439M 1.21B 15.39B 1.16B 1.13B 48.73B | P/E 2026 * |
28.4x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.41B 244M 219M 202M 183M 342M 23.26B 347M 961M 12.17B 917M 897M 38.55B | EV / Sales 2026 * |
2.35x | EV / Sales 2027 * | 2x |
| Free-Float |
70.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| SUS | Delayed | |
CBOE
| Real-time | ||
|
Tradegate
| 4P41 | Real-time | |
|
Xetra
| 4P41 | Delayed | |
|
OTC Markets
| SUSRF | Delayed | |
|
Boerse Muenchen
| 4P41 | Real-time | |
|
Deutsche Boerse AG
| 4P41 | Delayed | |
|
Börse Stuttgart
| 4P41 | Delayed | |
|
CBOE
| 0AAU | Real-time |
Last Transcript: Surgical Science Sweden AB
| 1 day | -2.26% | ||
| 1 week | +1.48% | ||
| Current month | +13.76% | ||
| 1 month | +16.97% | ||
| 3 months | +71.77% | ||
| 6 months | +79.27% | ||
| Current year | +79.38% |
| 1 week | 56 |  | 61.5 |
| 1 month | 48.8 | | 61.5 |
| Current year | 23.7 | | 61.5 |
| 1 year | 23.7 | | 85.85 |
| 3 years | 23.7 | | 196.9 |
| 5 years | 23.7 | | 333.5 |
| 10 years | 8.86 | | 333.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anders Larsson
CTO | Chief Tech/Sci/R&D Officer | 53 | 1997-07-23 |
Tom Englund
CEO | Chief Executive Officer | 50 | 2024-09-30 |
| Director of Finance/CFO | 56 | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Bengtsson
BRD | Director/Board Member | 82 | 2004-12-31 |
Roland Bengtsson
CHM | Chairman | 71 | 2010-12-31 |
| Director/Board Member | 59 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/22/26 | Free | Chief Executive Officer | 50,000 | 0.0980% | ||
| 12/12/25 | Buy | Chief Financial Officer | 3,000 | 0.0059% | ||
| 12/1/25 | Buy | Chief Executive Officer | 20,000 | 0.0392% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.26% | +1.48% | -31.17% | -52.21% | 307M | |
| +0.12% | +4.29% | +26.38% | +62.54% | 260B | |
| +0.34% | +2.22% | +9.74% | +26.88% | 165B | |
| +0.87% | +1.10% | -16.53% | +73.60% | 154B | |
| -1.18% | -8.75% | -58.14% | -16.11% | 61.49B | |
| +2.93% | +4.91% | +14.30% | +51.56% | 52.9B | |
| +0.70% | +2.71% | -13.09% | -6.29% | 52.84B | |
| -1.74% | -3.32% | +8.78% | +63.89% | 51.46B | |
| -0.69% | +3.66% | +25.87% | +78.17% | 51.16B | |
| +0.10% | +4.93% | +39.19% | +101.97% | 46.85B | |
| Average | -0.08% | +1.57% | +0.53% | +38.40% | 89.6B | |
| Weighted average by Cap. | +0.24% | +1.41% | +6.72% | +50.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.02B 104M 93.07M 85.86M 77.7M 145M 9.89B 148M 409M 5.18B 390M 382M 16.4B | 1.14B 116M 104M 95.65M 86.56M 162M 11.02B 164M 455M 5.77B 434M 425M 18.27B |
| Net income | 107M 10.88M 9.74M 8.99M 8.13M 15.21M 1.04B 15.45M 42.77M 542M 40.81M 39.94M 1.72B | 150M 15.18M 13.59M 12.54M 11.35M 21.22M 1.45B 21.57M 59.69M 756M 56.96M 55.75M 2.4B |
| Net Debt | -636M -64.5M -57.77M -53.3M -48.23M -90.19M -6.14B -91.65M -254M -3.21B -242M -237M -10.18B | -763M -77.41M -69.34M -63.97M -57.89M -108M -7.37B -110M -304M -3.86B -291M -284M -12.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | SEK 58.30 | -2.26% | 123,694 |
| 26-10-28 | SEK 59.65 | +1.97% | 168,663 |
| 26-10-27 | SEK 58.50 | +2.36% | 184,624 |
| 26-10-26 | SEK 57.15 | -0.09% | 142,672 |
| 26-10-23 | SEK 57.20 | -0.44% | 61,920 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUS Stock
Select your edition
All financial news and data tailored to specific country editions
